What does Open Labels and Price Tags conclude, in numbers, about “Telling People It Is a Sugar Pill: Three Tests of Open-Label Placebo”?
Answer: Chapter 1 recomputes three tests of open-label placebo: a day-21 effect size of 0.788 in the 2010 pilot; 0.434 for open label against no pill in the three-arm trial of 2021, barely different from double-blind placebo; and 0.39 for self-reported against only 0.09 for objective outcomes in the meta-analysis of 2025.
Scope of the numbers: Its parameters are illustrative; all calculations are generated by its programs; it is not medical advice, claims no effect of any product or practice on the body or on health, and its procedures and tool are non-personalised business guidance. Marked boxes separate published evidence, runnable Python calculations (21 programs), classical sources and the author's hypotheses.
Data table
The numbers below are printed verbatim by the chapter's Python program and can be reproduced by running it. standard-library Python onlyprinted values that match the answer: 0.09, 0.39, 2021, 2025
| estimate SMD SE P(sup) NNT | |
| 2021, 11 trials | 0.72 0.168 0.695 2.6 |
| 2025 overall | 0.35 0.046 0.598 5.1 |
| 2025 clinical | 0.47 0.054 0.630 3.8 |
| 2025 non-clinical | 0.29 0.064 0.581 6.2 |
| 2025 self-report | 0.39 0.048 0.609 4.6 |
| 2025 objective | 0.09 0.105 0.525 19.7 |
| 2025 trim-and-fill | 0.28 0.048 0.578 6.4 |
| self-report minus objective | 0.30, SE 0.115, z 2.60, p 0.0093 |
| objective share of self-report effect | 0.231 |
| 2025 clinical over 2021 estimate | 0.653 |
| implied spread of true effects (tau, approx) | 0.265 |
| share of settings with true SMD below 0 | 0.094 |
Show the full program
# Chapter 1. p13: Two meta-analyses, four years apart, and the gap
# between self-reported and objective outcomes.
# Published inputs: von Wernsdorff et al. (2021), Sci Rep: 11 trials,
# SMD 0.72 (95% CI 0.39 to 1.05). Fendel et al. (2025), Sci Rep: 63
# comparisons, n 4554, SMD 0.35 (0.26 to 0.44), prediction interval
# -0.17 to 0.87; clinical 0.47 (0.36 to 0.57); non-clinical 0.29 (0.17
# to 0.42); self-report 0.39 (0.30 to 0.49); objective 0.09 (-0.12 to
# 0.29); trim-and-fill 0.28 (0.18 to 0.37). SEs from the CIs, the
# z test of the self-report vs objective gap and the conversions are ours.
# 两次元分析:效应量的缩水与「自评 vs 客观」的落差。
import math
from statistics import NormalDist
Z = NormalDist()
Z975 = Z.inv_cdf(0.975)
ROWS = [("2021, 11 trials", 0.72, 0.39, 1.05),
("2025 overall", 0.35, 0.26, 0.44),
("2025 clinical", 0.47, 0.36, 0.57),
("2025 non-clinical", 0.29, 0.17, 0.42),
("2025 self-report", 0.39, 0.30, 0.49),
("2025 objective", 0.09, -0.12, 0.29),
("2025 trim-and-fill", 0.28, 0.18, 0.37)]
def nnt(d):
# Kraemer and Kupfer: 1 / (2 * P(superiority) - 1)
return 1 / (2 * Z.cdf(d / math.sqrt(2)) - 1)
print("estimate SMD SE P(sup) NNT")
se = {}
for name, d, lo, hi in ROWS:
se[name] = (hi - lo) / (2 * Z975)
print("{:<19} {:5.2f} {:.3f} {:.3f} {:5.1f}".format(
name, d, se[name], Z.cdf(d / math.sqrt(2)), nnt(d)))
gap = 0.39 - 0.09
s = math.hypot(se["2025 self-report"], se["2025 objective"])
z = gap / s
print("self-report minus objective: {:.2f}, SE {:.3f}, z {:.2f}, p {:.4f}"
.format(gap, s, z, 2 * (1 - Z.cdf(z))))
print("objective share of self-report effect: {:.3f}".format(0.09 / 0.39))
print("2025 clinical over 2021 estimate: {:.3f}".format(0.47 / 0.72))
tau = (0.87 - 0.35) / Z975
print("implied spread of true effects (tau, approx): {:.3f}".format(tau))
print("share of settings with true SMD below 0: {:.3f}"
.format(Z.cdf(-0.35 / tau)))Single source and citation
Fan, Y. (2026). Open-Label Placebos and Predictive Coding, Price-Tag Expectancy Gains and the Nocebo of the Bow in the Cup (Version 1.0.0), Chapter 1: Telling People It Is a Sugar Pill: Three Tests of Open-Label Placebo. 5D Library. DOI pending
DOI pending · monograph page goes live after publication · 5DL-B-201 · v1.0.0 · CC-BY-NC-ND-4.0
BibTeX
@book{fan2026201,
author = {Fan, Yafu},
title = {Open-Label Placebos and Predictive Coding, Price-Tag Expectancy Gains and the Nocebo of the Bow in the Cup},
year = {2026},
publisher = {5D Library},
edition = {1.0.0},
note = {DOI pending}
}Other chapter answers in this book
- Chapter 2 · Two Dollars Fifty or Ten Cents: the Expectancy Gain of a Price Tag and its Winner's Curse
- Chapter 3 · The Posterior Is a Weighted Mean: Precision-Weighted Perception and Price as a Shift of the Prior
- Chapter 4 · Where the Weight Comes From: Conditioned Learning, Rationale and the Additivity of Ritual
- Chapter 5 · Nocebo: the Same Formula with a Minus Sign
- Chapter 6 · The Sceptic's Three Knives: Regression to the Mean, Reporting Bias and the "Powerless Placebo"
- Chapter 7 · Classical Sources East and West: Du Xuan's Snake in the Cup and Franklin's Blindfolded Boy
- Chapter 8 · Closing the Loop: Expectation Management, Ritualised Delivery and Blinded Satisfaction Comparisons for High-Priced Experiences